Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Abercrombie & Fitch
ANF
$4.98B
| $39M | 0.01% |
1,036,430
-27,972
| -3% | -$1.08M |
|
|
SVC
1477
Service Properties Trust
SVC
$1.1B
| $38.9M | 0.01% |
693,845
+6,050
| +0.9% | +$344K |
|
1478
HUB Group
HUBG
$2.52B
| $38.9M | 0.01% |
1,131,150
-34,110
| -3% | -$1.15M |
|
|
AAWW
1479
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $38.8M | 0.01% |
475,585
-42,414
| -8% | -$3.05M |
|
|
NSTG
1480
DELISTED
NanoString Technologies, Inc.
NSTG
| $38.8M | 0.01% |
808,394
+9,342
| +1% | +$537K |
|
1481
Kadant
KAI
$3.98B
| $38.8M | 0.01% |
190,096
+453
| +0.2% | +$89.3K |
|
1482
Array Technologies
ARRY
$795M
| $38.8M | 0.01% |
2,094,095
+45,540
| +2% | +$755K |
|
1483
Brady Corp
BRC
$4.53B
| $38.8M | 0.01% |
764,568
-102,728
| -12% | -$5.41M |
|
|
SAGE
1484
DELISTED
Sage Therapeutics
SAGE
| $38.8M | 0.01% |
874,805
+101,121
| +13% | +$4.64M |
|
1485
Piper Sandler
PIPR
$5.36B
| $38.8M | 0.01% |
1,119,692
-96,356
| -8% | -$3.23M |
|
|
SJI
1486
DELISTED
South Jersey Industries, Inc.
SJI
| $38.7M | 0.01% |
1,822,345
-41,533
| -2% | -$1.02M |
|
1487
Antero Midstream
AM
$10.6B
| $38.7M | 0.01% |
3,712,355
+174,115
| +5% | +$1.71M |
|
1488
Federal Signal
FSS
$7.71B
| $38.7M | 0.01% |
1,001,545
+8,519
| +0.9% | +$335K |
|
1489
J&J Snack Foods
JJSF
$1.7B
| $38.7M | 0.01% |
252,939
-8,644
| -3% | -$1.41M |
|
|
SRNE
1490
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $38.6M | 0.01% |
5,059,333
+653,387
| +15% | +$5.54M |
|
|
CVA
1491
DELISTED
Covanta Holding Corporation
CVA
| $38.6M | 0.01% |
1,917,712
-60,496
| -3% | -$1.2M |
|
1492
Ligand Pharmaceuticals
LGND
$5.85B
| $38.5M | 0.01% |
442,452
-2,477
| -0.6% | -$192K |
|
1493
ArcBest
ARCB
$3.2B
| $38.4M | 0.01% |
470,156
+5,593
| +1% | +$369K |
|
1494
Telephone and Data Systems
TDS
$3.89B
| $38.3M | 0.01% |
1,965,081
+280,259
| +17% | +$5.82M |
|
|
ACCD
1495
DELISTED
Accolade Inc
ACCD
| $38.3M | 0.01% |
908,219
+337,914
| +59% | +$15.9M |
|
1496
John Wiley & Sons Class A
WLY
$2.57B
| $38.2M | 0.01% |
731,508
-7,358
| -1% | -$422K |
|
1497
Pediatrix Medical
MD
$2.16B
| $38.2M | 0.01% |
1,342,268
+712
| +0.1% | +$21.7K |
|
1498
Certara
CERT
$1.23B
| $38.1M | 0.01% |
1,151,765
+607,141
| +111% | +$18.3M |
|
1499
Cohen & Steers
CNS
$4.4B
| $38M | 0.01% |
454,160
-11,357
| -2% | -$962K |
|
1500
AppFolio
APPF
$6.99B
| $38M | 0.01% |
315,980
+4,588
| +1% | +$596K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.